Finland · Biotechnology startup
Finland · FinVector
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products.
Funding reportedLast round: Debt financing
What company datasets say FinVector raised
Funding, as reported
Reported in all45Min the source's currency
Rounds1
Last roundDebt financing
Last round dateJun 2023
Investors listed1
Founders and team
From FinVector's own website: 13 on the team.
- André OvermeyerBoard member
- Ann-Kristin JenssenQuality Unit Director
- Elisa KajanderManufacturing Director
- Giuseppe CarloniChairman of the board
- Jean-Frédéric PaulsenBoard member
- Mathieu FlechellePlanning & Supply Director
- Matthias KriegerManaging Director
- Mikko KämäräinenPMO Director
- Sanna LeskinenFinance Director
- Snorri HalldórssonEngineering & MSAT Director
- Supply ChainPlanning & Supply Director
- Tiina BiesHR Director
- Wolfram CariusBoard member
Biotechnology in Finland
Startups like it
Is this your company?
Add your raise, your deck and your story, and put FinVector in front of investors. Or tell us what we have wrong.